SHAHNAZ AHMED: Open Payments
NPI 1780681049 · BRADENTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$755 in 34 payments from 12 companies in 2025. Trend: 2023 $1,609 · 2024 $1,226 · 2025 $755
Food & beverage: $755
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $143 |
| Novartis Pharmaceuticals Corporation | 5 | $114 |
| PFIZER INC. | 5 | $108 |
| Lilly USA, LLC | 5 | $97 |
| Amgen Inc. | 3 | $49 |
| Exact Sciences Corporation | 2 | $45 |
| Daiichi Sankyo Inc. | 2 | $43 |
| Novo Nordisk Inc | 2 | $43 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Philips North America LLC | 2 | $33 |
Products named: LEQVIO, FARXIGA, MOUNJARO, AIRSUPRA, Cologuard Collection Kit, INJECTAFER, PAXLOVID, TRELEGY ELLIPTA.
Industry payments across FL — which companies pay providers there.
